Agonist-independent modulation of N-type calcium channels by ORL1 receptors

Nature Neuroscience

Volumn 7, Issue 2, 2004, Pages 118-125

  Beedle, Aaron M ^a   McRory, John E ^a   Poirot, Olivier ^b   Doering, Clinton J ^a   Altier, Christophe ^a   Barrere, Christian ^b   Hamid, Jawed ^a   Nargeot, Joel ^b   Bourinet, Emmanuel ^b   Zamponi, Gerald W ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b INSTITUT DE GÉNOMIQUE FONCTIONNELLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL N TYPE; CALCIUM CHANNEL T TYPE; G PROTEIN COUPLED RECEPTOR; NIFEDIPINE; NOCICEPTIN; NOCICEPTIN RECEPTOR AGONIST; OMEGA AGATOXIN IVA; OMEGA CONOTOXIN GVIA; OPIATE AGONIST; VOLTAGE GATED CALCIUM CHANNEL;

ANIMAL CELL; ARTICLE; CALCIUM CURRENT; CALCIUM SIGNALING; CONTROLLED STUDY; DRUG TOLERANCE; GENETIC TRANSFECTION; IMMUNOPRECIPITATION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPINAL GANGLION;

ANIMALS; BLOTTING, WESTERN; CALCIUM CHANNELS, N-TYPE; CELLS, CULTURED; GANGLIA, SPINAL; GTP-BINDING PROTEINS; HUMANS; MICROSCOPY, CONFOCAL; NEURONS; OPIOID PEPTIDES; PATCH-CLAMP TECHNIQUES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFECTION; VASODILATOR AGENTS;

EID: 9144233475     PISSN: 10976256     EISSN: None     Source Type: Journal    
DOI: 10.1038/nn1180     Document Type: Article

References (50)

1. Beedle, A.M. & Zamponi, G.W. Modulation of high voltage-activated calcium channels by G protein-coupled receptors. in Calcium Channel Pharmacology (ed., McDonough, S.) (Kluwer Academic/Plenum Publishing, New York, 2003).
2. Bunzow, J.R. et al. Molecular cloning and tissue distribution of a putative member of the rat opioid receptor gene family that is not a mu, delta or kappa opioid receptor type. FEBS Lett. 347, 284-288 (1994).
3. Bertorelli, R. et al. Nociceptin and the ORL-1 ligand [Phelpsi (CH2-NH)Gly2]nociceptin(1-13)NH2 exert anti-opioid effects in the Freund's adjuvant-induced arthritic rat model of chronic pain. Br. J. Pharmacol. 128, 1252-1258 (1999).
4. Ahmadi, S., Liebel, J.T. & Zeilhofer, H.U. The role of the ORL1 receptor in the modulation of spinal neurotransmission by nociceptin/orphanin FQ and nocistatin. Eur. J. Pharmacol. 412, 39-44 (2001).
5. Mollereau, C., Moisand, C., Butour, J.L., Parmentier, M. & Meunier, J.C. Replacement of Gln280 by His in TM6 of the human ORL1 receptor increases affinity but reduces intrinsic activity of opioids. FEBS Lett. 395, 17-21 (1996).
6. Xu, X., Hao, J.W. & Wiesenfeld-Hallin, Z. Nociceptin of antinociceptin: potent spinal antinociceptive effect of orphanin FQ/nociceptin in the rat. Neuroreport 7, 2092-2094 (1996).
7. Knoflach, F., Reinscheid, R.K., Civelli, O. & Kemp, J.A. Modulation of voltage-gated calcium channels by orphanin FQ in freshly dissociated hippocampal neurons. J. Neurosci. 16, 6657-6664 (1996).
8. 2+ channel currents of acutely dissociated rat periaqueductal grey neurons. J. Physiol. 15, 47-58 (1998).
9. 2+ channels in rat sympathetic ganglion neurons. Neurosci. Lett. 296, 121-124 (2000).
10. 2+ channel inhibition and its desensitization in NG108-15 cells. Eur. J. Pharmacol. 351, 247-252 (1998).
11. 2+ channel current in rat sensory neurons by a G-protein-independent mechanism. J. Neurosci. 17, 8721-8728 (1997).
12. Borgland, S.L., Connor, M. & Christie, M.J. Nociceptin inhibits calcium channel currents in a subpopulation of small nociceptive trigeminal ganglion neurons in mouse. J. Physiol. 536, 35-47 (2001).
13. Zamponi, G.W. Determinants of G protein inhibition of presynaptic calcium channels. Cell. Biochem. Biophys. 34, 79-94 (2001).
14. Koch, W.J., Hawes, B.E., Inglese, J., Luttrell, L.M. & Lefkowitz, R.J. Cellular expression of the carboxyl terminus of a G protein-coupled receptor kinase attenuates G beta gamma-mediated signalling. J. Biol. Chem. 269, 6193-6197 (1994).
15. Albert, P.R., Morris, S.J., Ghahremani, M.H., Storring, J.M. & Lembo, P.M. A putative alpha-helical G beta gamma-coupling domain in the second intracellular loop of the 5-HTIA receptor. Ann. NYAcad. Sci. 861, 146-161 (1998).
16. Lembo, P.M., Ghahremani, M.H., Morris, S.J. & Albert, P.R. A conserved threonine residue in the second intracellular loop of the 5-hydroxytryptamine 1A receptor directs signalling specificity. Mol. Pharmacol. 52, 164-171 (1997).
17. Wu, X., Kushwaha, N., Albert, P.R. & Penington, N.J. A critical protein kinase C phosphorylation site on the 5-HT(1A) receptor controlling coupling to N-type calcium channels. J. Physiol. 538, 41-51 (2002).
18. Arnot, M.I., Stotz, S.C., Jarvis, S.E. & Zamponi, G.W. Differential modulation of N-type 1B and P/Q-type 1A calcium channels by different G protein subunit isoforms. J. Physiol. 527, 203-212 (2000).
19. Beech, D.J., Bernheim, L. & Hille, B. Pertussis toxin and voltage dependence distinguish multiple pathways modulating calcium channels of rat sympthetic neurons. Neuron 8, 90-106 (1992).
20. Luebke, J.I. & Dunlap, K.I. Sensory neuron N-type calcium currents are inhibited by both voltage-dependent and -independent mechnaisms. Pflugers Arch. 428, 499-507 (1994).
21. q/11 and Gβγ. J. Neurosci. 20, 5623-5629 (2000).
22. Schiff, M.L. et al. Tyrsoine-kinase-dependent recruitment of RGS12 to the N-type calcium channel. Nature 408, 723-727 (2000).
23. Diverse-Pieluissi, M., Goldsmith, P.K. & Dunlap, K. Transmitter-mediated inhibition of N-type calcium channels in sensory neurons involves multiple GTP-binding proteins and subunits. Neuron 14, 191-200 (1995).
24. De Waard, M. et al. Direct binding of G-protein betagamma complex to voltage-dependent calcium channels. Nature 385, 446-450 (1997).
25. 2+ channels by G protein βγ subunits. Nature 380, 258-262 (1996).
26. Ikeda, S.R. Voltage-dependent modulation of N-type calcium channels by G-protein βγ subunits. Nature 380, 255-258 (1996).
27. Zamponi, G.W., Bourinet, E., Nelson, D., Nargeot, J. & Snutch, T.P. Crosstalk between G proteins and protein kinase C mediated by the calcium channel alphal subunit. Nature 385, 442-446 (1997).
28. Seifert, R. & Wenzel-Seifert, K. Constitutive activity of G protein-coupled receptors: cause of disease and common property of wild-type receptors. Nauyn Schmiedebergs Arch. Pharmacol. 366, 381-416 (2002).
29. 2+ channel Cav1.2. Science 293, 98-101 (2001).
30. Lavine, N. et al. G protein-coupled receptors form stable complexes with inwardly rectifying potassium channels and adenylyl cyclase. J. Biol. Chem. 277, 46010-46019 (2002).
31. Emmerson, P.J. & Miller, R.J. Pre- and postsynaptic actions of opioid and orphan opioid agonists in the rat arcuate nucleus and ventromedial hypothalamus in vitro. J. Physiol. 517, 431-445 (1999).
32. Meis. S. & Pape, H.C. Control of glutamate and GABA release by nociceptin/orphanin FQ in the rat lateral amygdala. J. Physiol. 532, 701-712 (2001).
33. Tallent, M.K., Madamba, S.G. & Siggins, G.R. Nociceptin reduces epileptiform events in CA3 hippocampus via presynaptic and postsynaptic mechanisms. J. Neurosci. 21. 6940-6948 (2001).
34. Venkatesan, P., Wang. J., Evans, C., Irnaten, M. & Mendelowitz, D. Nociceptin inhibits gamma-aminobutyric acidergic inputs to cardiac parasympathetic neurons in the nucleus ambiguus. J. Pharmacol. Exp. Ther. 300, 78-82 (2002).
35. Monteillet-Agius, G., Fein, J., Anton, B. & Evans, C.J. ORL-1 and mu opioid receptor antisera label different fibers in areas involved in pain processing. J. Comp. Neurol. 399, 373-383 (1998).
36. Neal, C.R. et al. Localization of orphanin FQ (nociceptin) peptide and messenger RNA in the central nervous system of the rat. J. Comp. Neurol. 406, 503-547 (1999).
37. Wick, M.J. et al. Isolation of a novel cDNA encoding a putative membrane receptor with high homology to the cloned mu, delta, and kappa opioid receptors. Brain Res. Mol. Brain Res. 27, 37-44 (1994).
38. Manabe, T. et al. Facilitation of long-term potentiation and memory in mice lacking nociceptin receptors. Nature 394, 577-581 (1998).
39. Briscini, L., Corradini, L., Ongini, E. & Bertorelli, R. Up-regulation of ORL-1 receptors in spinal tissue of allodynic rats after sciatic nerve injury. Eur. J. Pharmacol. 447, 59-65 (2002).
40. Gouarderes, C., Tafani, J.A., Meunier, J., Jhamandas, K. & Zajac, J. Nociceptin receptors in the rat spinal cord during morphine tolerance. Brain Res. 838, 85-94 (1999).
41. Jia, Y., Linden, D.R., Serie, J.R. & Seybold, V. S. Nociceptin/orphanin FQ binding increases in superficial laminae of the rat spinal cord during persistent peripheral inflammation. Neurosci. Lett. 250, 21-24 (1998).
42. Kest, B. et al. Morphine tolerance and dependence in nociceptin/orphanin FQ transgenic knock-out mice. Neurosci. 104, 217-222 (2001).
43. Ueda, H., Inoue, M., Takeshima, H. & Iwasawa, Y. Enhanced spinal nociceptin receptor expression develops morphine tolerance and dependence. J. Neurosci. 20, 7640-7647 (2000).
44. 2+ channel subtypes in cultured astrocytes. Glia 41, 347-353 (2003).
45. Beedle, A.M., Hamid, J. & Zamponi, G.W. Inhibition of transiently expressed low-and high-voltage-activated calcium channels by trivalent metal cations. J. Membr. Biol. 187, 225-238 (2002).
46. Monteil, A. et al. Specific properties of T-type calcium channels generated by the human alpha 11 subunit. J. Biol. Chem. 275, 16530-16535 (2000).
47. Magga, J.M., Jarvis, S.E., Arnot, M.I., Zamponi, G.W. & Braun, J.E. Cysteine string protein regulates G protein modulation of N-type calcium channels. Neuron 28, 195-204 (2000).
48. Jarvis, S.E., Magga, J.M., Beedle, A.M., Braun, J.E. & Zamponi, G.W. G protein modulation of N-type calcium channels is facilitated by physical interactions between syntaxin 1A and Gbetagamma. J. Biol. Chem. 275, 6388-6394 (2000).
49. 2+ channel activation of ryanodine receptors. Neuron 40, 56-63 (2003).
50. Kaneko, S. et al. Identification and characterization of novel human Cav2.2 (alpha1B) calcium channel variants lacking the synaptic protein interaction site. J. Neurosci. 22, 82-92 (2002).